Andrew A. Davis

Oncology
4921 Parkview Pl
Saint Louis, MO 63110

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 65 publications

Real-World Analysis of Adverse Events in Patients With Triple-Negative Breast Cancer Receiving Therapy per KEYNOTE-522.

Real-World Analysis of Adverse Events in Patients With Triple-Negative Breast Cancer Receiving Therapy per KEYNOTE-522.

Journal: JCO oncology practice
Published: May 05, 2026

Dual-positive CTCs in patients with advanced breast cancer show metastatic potential and prognostic value.

Dual-positive CTCs in patients with advanced breast cancer show metastatic potential and prognostic value.

Journal: Science translational medicine
Published: March 11, 2026

Associations of neighborhood deprivation with breast cancer tumor genomics, targeted treatment use, and survival.

Associations of neighborhood deprivation with breast cancer tumor genomics, targeted treatment use, and survival.

Journal: Breast cancer research and treatment
Published: February 15, 2026

AADAT-Driven Metabolic Control of Malate and CoQ 10 Shapes Immune Evasion in Triple-Negative Breast Cancer.

AADAT-Driven Metabolic Control of Malate and CoQ 10 Shapes Immune Evasion in Triple-Negative Breast Cancer.

Journal: bioRxiv : the preprint server for biology
Published: February 09, 2026

ESR1 methylation and ESR1 mutations in circulating tumor cells (CTCs) and paired plasma-cfDNA of advanced breast cancer patients: A feasibility proof-of-concept study.

ESR1 methylation and ESR1 mutations in circulating tumor cells (CTCs) and paired plasma-cfDNA of advanced breast cancer patients: A feasibility proof-of-concept study.

Journal: Molecular oncology
Published: October 21, 2025

Impact of Financial Incentives on Electronic Health Record-Driven Recruitment of Underrepresented Communities in Research: Randomized Controlled Trial.

Impact of Financial Incentives on Electronic Health Record-Driven Recruitment of Underrepresented Communities in Research: Randomized Controlled Trial.

Journal: Journal of medical Internet research
Published: October 18, 2025

Reporting of immune-related adverse events in US Food and Drug Administration approvals of immune checkpoint inhibitors.

Reporting of immune-related adverse events in US Food and Drug Administration approvals of immune checkpoint inhibitors.

Journal: Frontiers in oncology
Published: April 05, 2025

Racial Differences in ctDNA Profiles, Targeted Therapy Use, and Outcomes in Metastatic Breast Cancer.

Racial Differences in ctDNA Profiles, Targeted Therapy Use, and Outcomes in Metastatic Breast Cancer.

Journal: JAMA network open
Published: February 26, 2025

Molecular Characterization of Patients with Metastatic Invasive Lobular Carcinoma: Using Real-World Data to Describe This Unique Clinical Entity.

Molecular Characterization of Patients with Metastatic Invasive Lobular Carcinoma: Using Real-World Data to Describe This Unique Clinical Entity.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 21, 2025

Genomic and proteomic profiling of GATA3 mutant metastatic hormone receptor-positive breast cancer and impact on clinical outcomes.

Genomic and proteomic profiling of GATA3 mutant metastatic hormone receptor-positive breast cancer and impact on clinical outcomes.

Journal: Breast cancer research and treatment
Published: February 06, 2025

Modulation of HER2 internalization enhances single-dose antibody-drug potency in HER2+ gastric cancer.

Modulation of HER2 internalization enhances single-dose antibody-drug potency in HER2+ gastric cancer.

Journal: Scientific reports
Published: January 19, 2025

Novel treatment approaches utilizing antibody-drug conjugates in breast cancer.

Novel treatment approaches utilizing antibody-drug conjugates in breast cancer.

Journal: NPJ breast cancer
Published: December 30, 2024
Showing 1-12 of 65

Last Updated: 09/26/2026